See why thousands choose our centers as their preferred destination for ongoing care, including Glassia treatments.
Glassia is an infusion therapy that is indicated to treat:
- adults with clinically evident emphysema due to severe hereditary deficiency of Alpha1-PI (alpha1-antitrypsin deficiency).
Glassia is used to treat emphysema by raising the alpha1-antitrypsin protein levels. Patients receive a weekly infusion that typically lasts 15 minutes.
Patients chose IVX Health to receive their ongoing Glassia treatments because:
- ALL private suites
- Comfortable recliners, with chairs for guests
- Evening & weekend appointments
- Friendly clinical staff deliver personal service
- Big screen TVs, high-speed WiFi, free snacks
Interested in moving your care to IVX Health?
Glassia Financial Assistance Programs
Information about financial assistance programs coming soon.
Interested?
IVX Health would love to learn more about your care needs. If you’re interested in switching your infusion services – or if you just want to learn more – let us know.
